Simon Allen - Jun 27, 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Executive Officer, Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Stock symbol
ANEB
Transactions as of
Jun 27, 2022
Transactions value $
$0
Form type
4
Date filed
10/3/2022, 07:48 PM
Previous filing
Feb 7, 2022
Next filing
Dec 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +77.5K $0.00 77.5K Jun 27, 2022 Common Stock 77.5K $7.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 4,841 shares vest immediately. The remainder of the shares vest ratably in 15 quarterly installments (4,841.06 shares each Quarter) from July 1, 2022 through January 1, 2026. All shares subject to the option will vest immediately upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of the option on June 23, 2022.